5151 - 5200 of 6466 Results
Title
Year
-
OPENTitle: Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter MicrostructureJournal Name: Frontiers in EndocrinologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page: 608End Page: 608Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fendo.2018.00608Best OA location URL: https://www.frontiersin.org/articles/10.3389/fendo.2018.00608/pdfCitation Count: 20
-
OPENTitle: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 7Issue #:Start Page: 174End Page: 174Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2016.00174Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2016.00174/pdfCitation Count: 11
-
OPENTitle: Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page: 560End Page: 560Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2018.00560Best OA location URL: https://doi.org/10.3389/fneur.2018.00560Citation Count: 57
-
OPENTitle: White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Excessive Daytime SleepinessJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page: 378End Page: 378Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2019.00378Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2019.00378/pdfCitation Count: 12
-
OPENTitle: Pleiotropic Effects of Variants in Dementia Genes in Parkinson DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page: 230End Page: 230Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2018.00230Best OA location URL: https://doi.org/10.3389/fnins.2018.00230Citation Count: 28
-
OPENTitle: Longitudinal Connectomes as a Candidate Progression Marker for Prodromal Parkinson’s DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page: 967End Page: 967Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2018.00967Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2018.00967/pdfCitation Count: 24
-
OPENTitle: Validating new symptom emergence as a patient-centric outcome measure for PD clinical trialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107118End Page: 107118Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107118Best OA location URL: https://www.prd-journal.com/article/S1353-8020(24)01130-1/pdfCitation Count: 0
-
OPENTitle: Single-Molecule Fingerprinting Reveals Different Growth Mechanisms in Seed Amplification Assays for Different Polymorphs of α-Synuclein FibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 18Start Page: 3270End Page: 3285Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00185Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.4c00185?ref=article_openPDFCitation Count: 5
-
OPENTitle: Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegenerationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 382Issue #:Start Page: 114959End Page: 114959Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114959Best OA location URL: https://doi.org/10.1016/j.expneurol.2024.114959Citation Count: 8
-
OPENTitle: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107158End Page: 107158Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158Best OA location URL: https://www.prd-journal.com/article/S1353-8020(24)01170-2/pdfCitation Count: 3
- Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort2024OPENTitle: Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) CohortJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 7Start Page: 1481End Page: 1494Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-240213Best OA location URL: https://doi.org/10.3233/jpd-240213Citation Count: 9
- Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late‐onset cerebellar ataxia2023OPENTitle: Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late‐onset cerebellar ataxiaJournal Name: European Journal of NeurologyPublisher: WileyVol: 30Issue #: 12Start Page: 3828End Page: 3833Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.16039Citation Count: 41
-
OPENTitle: Post‐Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10 Years CERE120 DeliveryJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 9Start Page: 1728End Page: 1736Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29518Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29518Citation Count: 25
-
OPENTitle: Interaction of Mitochondrial Polygenic Score and Lifestyle Factors in LRRK2 p.Gly2019Ser ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 10Start Page: 1837End Page: 1849Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29563Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29563Citation Count: 23
- Wearables for Parkinson's: Fast‐Paced toward Novel Outcome Measures2023OPENTitle: Wearables for Parkinson's: Fast‐Paced toward Novel Outcome MeasuresJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 11Start Page: 1988End Page: 1989Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29608Citation Count: 1
- The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?2023OPENTitle: The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 2Start Page: 273End Page: 293Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29688Citation Count: 11
-
OPENTitle: Targeting Rab‐RILPL interactions as a strategy to downregulate pathogenic LRRK2 in Parkinson's diseaseJournal Name: Journal of Peptide SciencePublisher: WileyVol: 30Issue #: 5Start Page: e3563End Page: e3563Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/psc.3563Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psc.3563Citation Count: 4
-
OPENTitle: Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 271Issue #: 3Start Page: 1483End Page: 1491Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-023-12073-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-023-12073-7.pdfCitation Count: 13
-
OPENTitle: Toward Omics-Scale Quantitative Mass Spectrometry Imaging of Lipids in Brain Tissue Using a Multiclass Internal Standard MixtureJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 95Issue #: 51Start Page: 18719End Page: 18730Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.analchem.3c02724Best OA location URL: https://doi.org/10.1021/acs.analchem.3c02724Citation Count: 46
-
OPENTitle: Apathy as a Within-Person Mediator of Depressive Symptoms and Cognition in Parkinson's Disease: Longitudinal Mediation AnalysesJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 30Issue #: 6Start Page: 664End Page: 674Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2021.11.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9106826Citation Count: 19
-
OPENTitle: PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista JunctionsJournal Name: Molecular CellPublisher: Elsevier BVVol: 69Issue #: 5Start Page: 744End Page: 756.e6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2018.01.026Best OA location URL: http://www.cell.com/article/S1097276518300558/pdfCitation Count: 118
-
OPENTitle: Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site studyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 1097End Page: 1104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.10.029Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.10.029Citation Count: 168
-
OPENTitle: Lack of evidence for association of UQCRC1 with Parkinson's disease in EuropeansJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 101Issue #:Start Page: 297.e1End Page: 297.e4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.030Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8938960Citation Count: 14
-
OPENTitle: Assessment of ANG variants in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 104Issue #:Start Page: 111.e1End Page: 111.e4Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.03.006Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.03.006Citation Count: 3
-
OPENTitle: The Image and Data Archive at the Laboratory of Neuro ImagingJournal Name: NeuroImagePublisher: Elsevier BVVol: 124Issue #:Start Page: 1080End Page: 1083Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2015.04.067Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4644502Citation Count: 68
-
OPENTitle: Normative data for subcortical regional volumes over the lifetime of the adult human brainJournal Name: NeuroImagePublisher: Elsevier BVVol: 137Issue #:Start Page: 9End Page: 20Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2016.05.016Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S1053811916301355?via%3DihubCitation Count: 139
-
OPENTitle: Association of Cerebrospinal Fluid Neurofilament Heavy Protein Levels With Clinical Progression in Patients With Parkinson DiseaseJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 5Issue #: 7Start Page: e2223821End Page: e2223821Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.23821Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2794635/wang_2022_oi_220672_1659467066.66779.pdfCitation Count: 13
-
OPENTitle: Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 1Start Page: 30End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2020.3311Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2771032/jamaneurology_wang_2020_oi_200066_1610037478.56504.pdfCitation Count: 253
- Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease2020OPENTitle: Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 7Issue #: 4Start Page: 449End Page: 461Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51022Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51022Citation Count: 84
-
OPENTitle: Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patientsJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 7Issue #: 10Start Page: 1816End Page: 1830Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51164Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51164Citation Count: 40
-
OPENTitle: Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorderJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 1Start Page: 201End Page: 212Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51269Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51269Citation Count: 62
-
OPENTitle: SORL1 mutation in a Greek family with Parkinson's disease and dementiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 10Start Page: 1961End Page: 1969Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51433Best OA location URL: https://doi.org/10.1002/acn3.51433Citation Count: 11
-
OPENTitle: An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 CohortsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 623End Page: 629Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191786Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191786?id=journal-of-parkinsons-disease%2Fjpd191786Citation Count: 49
-
OPENTitle: Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 TrialsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1663End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212672Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212672?id=journal-of-parkinsons-disease%2Fjpd212672Citation Count: 42
-
OPENTitle: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 557End Page: 570Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212714Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212714?id=journal-of-parkinsons-disease%2Fjpd212714Citation Count: 61
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 89
-
OPENTitle: Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 648417End Page: 648417Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.648417Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.648417/pdfCitation Count: 11
-
OPENTitle: α‐synuclein genetic variability: A biomarker for dementia in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 6Start Page: 991End Page: 999Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24664Best OA location URL: http://hdl.handle.net/2027.42/137619Citation Count: 98
- A comprehensive analysis of SNCA‐related genetic risk in sporadic parkinson disease2018OPENTitle: A comprehensive analysis of SNCA‐related genetic risk in sporadic parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 84Issue #: 1Start Page: 117End Page: 129Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25274Citation Count: 67
-
OPENTitle: Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 3Start Page: 574End Page: 587Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25811Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25811Citation Count: 110
- Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease2024OPENTitle: Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 6Start Page: 1162End Page: 1172Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26923Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26923Citation Count: 22
-
OPENTitle: Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patientsJournal Name: Clinical and Translational DiscoveryPublisher: WileyVol: 2Issue #: 2Start Page: e96End Page: e96Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/ctd2.96Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ctd2.96Citation Count: 6
-
OPENTitle: Sex Disparities in Autonomic Symptom Treatment in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 718End Page: 719Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12997Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12997Citation Count: 8
-
OPENTitle: Modifiable Comorbidities Associated with Cognitive Decline in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 2Start Page: 254End Page: 263Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13143Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13143Citation Count: 18
-
OPENTitle: Dream Content Predicts Motor and Cognitive Decline in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1041End Page: 1051Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13318Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8485616Citation Count: 15
- Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years2024OPENTitle: Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 YearsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 6Start Page: 686End Page: 697Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.14044Best OA location URL: https://research-information.bris.ac.uk/en/publications/882c3e53-2aa7-4b20-9e98-9fa553842eb3Citation Count: 21
-
OPENTitle: Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 919End Page: 927Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26170Best OA location URL: http://doi.org/10.1002/mds.26170Citation Count: 307
- Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to Relatives2024OPENTitle: Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to RelativesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 7Start Page: 786End Page: 794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.14043Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14043Citation Count: 0
- Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression2016OPENTitle: Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progressionJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1535End Page: 1542Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26754Citation Count: 150
-
OPENTitle: Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative CohortJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 5Start Page: 771End Page: 782Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27361Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27361Citation Count: 205